Biosimilars in rheumatology: the wind of change

Ann Rheum Dis. 2013 Mar;72(3):315-8. doi: 10.1136/annrheumdis-2012-202941.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biosimilar Pharmaceuticals / pharmacokinetics
  • Biosimilar Pharmaceuticals / standards*
  • Humans
  • Rheumatology / trends*
  • Therapeutic Equivalency

Substances

  • Biosimilar Pharmaceuticals